| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
progesterone receptor | 0.426 | 0.885 | 5.1E-02 |
|
group | 0.400 | None | 0.981 | 80 | 0 | 1991 | 2020 | ||||||||
|
cytochrome P450 family 19 subfamily A member 1 | 0.410 | 0.885 | 1.7E-05 |
|
group | 0.400 | None | 1.000 | 69 | 0 | 1993 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.100 | None | 0.987 | 44 | 0 | 1996 | 2020 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
group | 0.100 | None | 1.000 | 37 | 0 | 1995 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
group | 0.100 | None | 1.000 | 28 | 0 | 2004 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.400 | None | 1.000 | 27 | 0 | 1992 | 2019 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
group | 0.400 | None | 1.000 | 27 | 0 | 2002 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.400 | None | 0.978 | 25 | 0 | 1998 | 2019 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
group | 0.400 | None | 1.000 | 23 | 0 | 1987 | 2019 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
group | 0.400 | None | 1.000 | 23 | 0 | 2001 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.300 | None | 1.000 | 22 | 0 | 1994 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
group | 0.400 | None | 0.944 | 22 | 0 | 1989 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
group | 0.400 | None | 1.000 | 20 | 0 | 2003 | 2018 | ||||||||
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
group | 0.500 | None | 1.000 | 19 | 0 | 1999 | 2018 | ||||||||
|
GATA binding protein 3 | 0.415 | 0.846 | 0.90 |
|
group | 0.100 | None | 1.000 | 18 | 0 | 2004 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.400 | None | 1.000 | 18 | 0 | 2001 | 2018 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
group | 0.400 | None | 0.979 | 17 | 0 | 1999 | 2018 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.957 | 16 | 0 | 2000 | 2018 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
group | 0.400 | None | 0.967 | 16 | 0 | 2003 | 2019 | ||||||||
|
Ras association domain family member 1 | 0.420 | 0.808 | 4.9E-06 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 2001 | 2014 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 2008 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.400 | None | 1.000 | 14 | 0 | 1987 | 2020 | ||||||||
|
proline, glutamate and leucine rich protein 1 | 0.612 | 0.577 | 1.00 |
|
group | 0.100 | None | 0.929 | 13 | 0 | 2001 | 2018 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.400 | None | 0.963 | 13 | 0 | 1996 | 2018 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
group | 0.400 | None | 0.950 | 13 | 0 | 2002 | 2019 |